cdn mobile

E-League for basketball: Results Manila routs Shearwater Health

By: Jonas Rey N. Panerio December 06,2018 - 07:57 PM

The Results Manila Spartans improved to 10-3 with a win last weekend. Contributed photo

The Results Manila Spartans claimed their 10th win after they routed the Shearwater Health Crusaders, 84-68, in the Evo League division of the Tanduay Athletics E-League for Basketball last Sunday at the City Sports Club-Cebu.

The Spartans improved to 10-3 (win-loss) as Jhade Lawas led the team in scoring with 14 points, while Eubel Balbuena and Jade Seno added 13 and 12 were, respectively.

Also winning in the Evo League were the Author Solutions Philippines Hardbacks and the SSI Warriors.

The Hardbacks nabbed ninth win in 13 matches with a 62-59 triumph over the Contact Solutions Flying Lemurs as versatile forward Sylvester Millevo piled up 27 points, six steals, four assists and three boards.

The SSI Warriors, meanwhile, stretched their winning streak to five, upping their record to 7-6 with a 78-42 defeat of the Optum Knights.

In the Elite Classic, the ePerformax Reds clobbered the Wipro Tigers, 84-79, to get their sixth victory in 15 games.

Big man Robert Gilo was unstoppable for the Reds as he fired in 27 points and grabbed 17 rebounds along with four blocked shots and two assists.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: basketball, E-League, health, Manila, results
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.